Skip to content

A retrospective study investigating the anxiety and depression level of novel coronavirus Omicron patients in 2022

A retrospective study investigating the anxiety and depression level of novel coronavirus Omicron patients in 2022

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063956
Enrollment
Unknown
Registered
2022-09-21
Start date
2022-09-21
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case series:None

Sponsors

Jiujiang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In accordance with the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 9) issued by the National Health Commission, the diagnosis of novel coronavirus was confirmed by the nucleic acid test of novel coronavirus; 2. Patients with definite prognosis (cured and discharged or died before June 15, 2022).

Exclusion criteria

Exclusion criteria: Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire-9 Score;The 7-item Generalized Anxiety Disorder Scale (GAD-7);

Secondary

MeasureTime frame
Self-rating Anxiety Scale Score;Epidemiological and clinical characteristics of patients with COVID-19;

Countries

China

Contacts

Public ContactWu Hongze
yihuihn@163.com+86 18970256865

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026